|
1
|
Milano F and Krishnadath KK:
Electroporation of dendritic cells with autologous total RNA from
tumor material. Methods Mol Biol. 1139:87–95. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Benteyn D, Van Nuffel AM, Wilgenhof S and
Bonehill A: Single-step antigen loading and maturation of dendritic
cells through mRNA electroporation of a tumor-associated antigen
and a TriMix of costimulatory molecules. Methods Mol Biol.
1139:3–15. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Aravindaram K, Wang PH, Yin SY and Yang
NS: Tumor- associated antigen/IL-21-transduced dendritic cell
vaccines enhance immunity and inhibit immunosuppressive cells in
metastatic melanoma. Gene Ther. 21:457–467. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Torchia Giardino ML, Ciaglia E, Masci AM,
Vitiello L, Fogli M, la Sala A, Mavilio D and Racioppi L: Dendritic
cells/natural killer cross-talk: A novel target for human
immunodeficiency virus type-1 protease inhibitors. PLoS One.
5:e110522010. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Benencia F, Sprague L, McGinty J, Pate M
and Muccioli M: Dendritic cells the tumor microenvironment and the
challenges for an effective antitumor vaccination. J Biomed
Biotechnol. 2012:4254762012. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Farren MR, Carlson LM, Netherby CS,
Lindner I, Li PK, Gabrilovich DI, Abrams SI and Lee KP:
Tumor-induced STAT3 signaling in myeloid cells impairs dendritic
cell generation by decreasing PKCβII abundance. Sci Signal.
7:ra162014. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Wu TC, Xu K, Banchereau R, Marches F, Yu
CI, Martinek J, Anguiano E, Pedroza-Gonzalez A, Snipes GJ,
O'Shaughnessy J, et al: Reprogramming tumor-infiltrating dendritic
cells for CD103+ CD8+ mucosal T-cell
differentiation and breast cancer rejection. Cancer Immunol Res.
2:487–500. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Peng G, Wang HY, Peng W, Kiniwa Y, Seo KH
and Wang RF: Tumor-infiltrating gammadelta T cells suppress T and
dendritic cell function via mechanisms controlled by a unique
toll-like receptor signaling pathway. Immunity. 27:334–348. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Young MR and Cigal M: Tumor skewing of
CD34+ cell differentiation from a dendritic cell pathway
into endothelial cells. Cancer Immunol Immunother. 55:558–568.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Conejo-Garcia JR, Benencia F, Courreges
MC, Kang E, Mohamed-Hadley A, Buckanovich RJ, Holtz DO, Jenkins A,
Na H, Zhang L, et al: Tumor-infiltrating dendritic cell precursors
recruited by a beta-defensin contribute to vasculogenesis under the
influence of Vegf-A. Nat Med. 10:950–958. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Gottfried E, Kreutz M, Haffner S, Holler
E, Iacobelli M, Andreesen R and Eissner G: Differentiation of human
tumour-associated dendritic cells into endothelial-like cells: An
alternative pathway of tumour angiogenesis. Scand J Immunol.
65:329–335. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Berger S, Dyugovskaya L, Polyakov A and
Lavie L: Short-term fibronectin treatment induces endothelial-like
and angiogenic properties in monocyte-derived immature dendritic
cells: Involvement of intracellular VEGF and MAPK regulation. Eur J
Cell Biol. 91:640–653. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Sozzani S, Rusnati M, Riboldi E, Mitola S
and Presta M: Dendritic cell-endothelial cell cross-talk in
angiogenesis. Trends Immunol. 28:385–392. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Osuka K, Usuda N, Aoyama M, Yamahata H,
Takeuchi M, Yasuda M and Takayasu M: Expression of the
JAK/STAT3/SOCS3 signaling pathway in herniated lumbar discs.
Neurosci Lett. 569:55–58. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Zang Y, Yu LF, Pang T, Fang LP, Feng X,
Wen TQ, Nan FJ, Feng LY and Li J: AICAR induces astroglial
differentiation of neural stem cells via activating the JAK/STAT3
pathway independently of AMP-activated protein kinase. J Biol Chem.
283:6201–6208. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Pennathur A, Gibson MK, Jobe BA and
Luketich JD: Oesophageal carcinoma. Lancet. 381:400–412. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Montgomery EA, Basman FT, Brennan P and
Malekzadeh R: Oesophageal Cancer. World Cancer Report 2014. Stewart
BW and Wild CP: (Lyon). IARC Press. 374–382. 2014.
|
|
18
|
Wang XX, Wang K, Li XZ, Zhai LQ, Qu CX,
Zhao Y, Liu ZR, Wang HZ, An QJ, Jing LW, et al: Targeted knockdown
of IQGAP1 inhibits the progression of esophageal squamous cell
carcinoma in vitro and in vivo. PLoS One. 9:e965012014. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Lu J, Zhao J, Liu K, Zhao J, Yang H, Huang
Y, Qin Z, Bai R, Li P, Ma J, et al: MAPK/ERK1/2 signaling mediates
endothelial-like differentiation of immature DCs in the
microenvironment of esophageal squamous cell carcinoma. Cell Mol
Life Sci. 67:2091–2106. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Aranguren XL, Luttun A, Clavel C, Moreno
C, Abizanda G, Barajas MA, Pelacho B, Uriz M, Araña M, Echavarri A,
et al: In vitro and in vivo arterial differentiation of human
multipotent adult progenitor cells. Blood. 109:2634–2642. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Li Z, Wu JC, Sheikh AY, Kraft D, Cao F,
Xie X, Patel M, Gambhir SS, Robbins RC, Cooke JP, et al:
Differentiation, survival, and function of embryonic stem cell
derived endothelial cells for ischemic heart disease. Circulation.
116(Suppl): I46–54. 2007.PubMed/NCBI
|
|
22
|
Lu J, Liu K, Zhao J, Zhao J, Ma J, Yang H,
Huang Y, Qin Z, Bai R, Jiang L, et al: VEGF-A not Ang2 mediates
endothelial-like differentiation of immature DCs by ERK1/2
signaling in the microenvironment of human colon adenocarcinoma.
Int J Oncol. 38:1579–1588. 2011.PubMed/NCBI
|
|
23
|
Lu J, Zhao J, Zhao J, Ma J, Liu K, Yang H,
Huang Y, Qin Z, Bai R, Li P, et al: VEGF-A-induced immature DCs not
mature DCs differentiation into endothelial-like cells through
ERK1/2-dependent pathway. Cell Biochem Funct. 29:294–302. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
El Deeb NM and Mehanna RA: Assessment of
maturation status of tumor-infiltrating dendritic cells in invasive
ductal carcinoma of the breast: Relation with vascular endothelial
growth factor expression. Turk Patoloji Derg. 29:193–200.
2013.PubMed/NCBI
|
|
25
|
Zhao Y, Glesne D and Huberman E: A human
peripheral blood monocyte-derived subset acts as pluripotent stem
cells. Proc Natl Acad Sci USA. 100:2426–2431. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Tang Y, Luo Y, Jiang Z, Lin CJ, Kim C,
Carter MG, Amano T, Park J, Kish S, et al: Jak/Stat3 signaling
promotes somatic cell reprogramming by epigenetic regulation. Stem
Cells. 30:2645–2656. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Nefedova Y and Gabrilovich DI: Targeting
of Jak/STAT pathway in antigen presenting cells in cancer. Curr
Cancer Drug Targets. 7:71–77. 2007. View Article : Google Scholar : PubMed/NCBI
|
